Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085584 (
encephalopathy
)
18,178
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We prospectively studied a cohort of 25 HIV-1 infected individuals with no clinical signs of
encephalopathy
with 99mTc-HMPAO-SPECT. The findings were correlated with magnetic resonance imaging (MRI), neuropsychological testing and clinical staging aiming at the early diagnosis of HIV encephalopathy by single photon emission computed tomography (SPECT). A total of 25 matched seronegative controls were subject to neuropsychological testing only. A total of 24 patients and controls were monitored for 6-46 months (mean and median 26 months). No patients developed AIDS dementia complex during the study; 3 patients developed minimal symptoms (
MSK
classification stage 0.5). There was a significant decline in 99mTc-HMPAO uptake over time and neuropsychological abnormalities progressed. Unexpectedly, there was a correlation of high cortical and subcortical 99mTc-HMPAO uptake and low performance in cognitive dysfunction tests, indicating a possible inflammatory reaction in the brain with increased blood flow due to HIV infection. We conclude that, in non-demented HIV-infected individuals, both the 99mTc-HMPAO uptake and functional level slowly decrease over time, but the regional cerebral blood flow decrease could be masked by a direct HIV-induced inflammatory reaction in the brain, which gives a 99mTc-HMPAO hyperfixation.
...
PMID:SPECT with 99mTc-HMPAO in subjects with HIV infection: cognitive dysfunction correlates with high uptake. 1052 71
Developmental epilepsies are age-dependent seizure disorders for which genetic causes have been increasingly identified. Here we report six unrelated individuals with mutations in
salt-inducible kinase 1
(
SIK1
) in a series of 101 persons with early myoclonic
encephalopathy
, Ohtahara syndrome, and infantile spasms. Individuals with
SIK1
mutations had short survival in cases with neonatal epilepsy onset, and an autism plus developmental syndrome after infantile spasms in others. All six mutations occurred outside the kinase domain of
SIK1
and each of the mutants displayed autophosphorylation and kinase activity toward HDAC5. Three mutations generated truncated forms of
SIK1
that were resistant to degradation and also showed changes in sub-cellular localization compared to wild-type
SIK1
. We also report the human neuropathologic examination of
SIK1
-related developmental epilepsy, with normal neuronal morphology and lamination but abnormal
SIK1
protein cellular localization. Therefore, these results expand the genetic etiologies of developmental epilepsies by demonstrating
SIK1
mutations as a cause of severe developmental epilepsy.
...
PMID:De novo mutations in SIK1 cause a spectrum of developmental epilepsies. 2583 29